當(dāng)前位置：首頁 JCRQ3 期刊介紹(非官網(wǎng))

Catheterization And Cardiovascular InterventionsSCIE

國際簡稱：CATHETER CARDIO INTE 參考譯名：導(dǎo)管插入和心血管干預(yù)

中科院分區(qū)
3區(qū)
CiteScore分區(qū)
Q1
JCR分區(qū)
Q3

基本信息：: ISSN：1522-1946; E-ISSN：1522-726X; 是否OA：未開放; 是否預(yù)警：否; TOP期刊：否

出版信息：: 出版地區(qū)：UNITED STATES; 出版商：Wiley-Liss Inc.; 出版語言：English; 出版周期：Monthly; 出版年份：1999; 研究方向：醫(yī)學(xué)-心血管系統(tǒng)

評價(jià)信息：: 影響因子：2.1; H-index：107; CiteScore指數(shù)：5.4; SJR指數(shù)：0.948; SNIP指數(shù)：0.859

發(fā)文數(shù)據(jù)：: Gold OA文章占比：18.43%; 研究類文章占比：89.97%; 年發(fā)文量：299; 自引率：0.0869...; 開源占比：0.1035; 出版撤稿占比：0; 出版國人文章占比：0.04; OA被引用占比：0.0748...

投稿咨詢加急見刊

英文簡介期刊介紹 CiteScore數(shù)據(jù) 中科院SCI分區(qū) JCR分區(qū) 發(fā)文數(shù)據(jù) 常見問題

英文簡介Catheterization And Cardiovascular Interventions期刊介紹

Catheterization and Cardiovascular Interventions is an international journal covering the broad field of cardiovascular diseases. Subject material includes basic and clinical information that is derived from or related to invasive and interventional coronary or peripheral vascular techniques. The journal focuses on material that will be of immediate practical value to physicians providing patient care in the clinical laboratory setting. To accomplish this, the journal publishes Preliminary Reports and Work In Progress articles that complement the traditional Original Studies, Case Reports, and Comprehensive Reviews. Perspective and insight concerning controversial subjects and evolving technologies are provided regularly through Editorial Commentaries furnished by members of the Editorial Board and other experts. Articles are subject to double-blind peer review and complete editorial evaluation prior to any decision regarding acceptability.

期刊簡介Catheterization And Cardiovascular Interventions期刊介紹

《Catheterization And Cardiovascular Interventions》自1999出版以來，是一本醫(yī)學(xué)優(yōu)秀雜志。致力于發(fā)表原創(chuàng)科學(xué)研究結(jié)果，并為醫(yī)學(xué)各個(gè)領(lǐng)域的原創(chuàng)研究提供一個(gè)展示平臺，以促進(jìn)醫(yī)學(xué)領(lǐng)域的的進(jìn)步。該刊鼓勵(lì)先進(jìn)的、清晰的闡述，從廣泛的視角提供當(dāng)前感興趣的研究主題的新見解，或?qū)彶槎嗄陙砟硞€(gè)重要領(lǐng)域的所有重要發(fā)展。該期刊特色在于及時(shí)報(bào)道醫(yī)學(xué)領(lǐng)域的最新進(jìn)展和新發(fā)現(xiàn)新突破等。該刊近一年未被列入預(yù)警期刊名單，目前已被權(quán)威數(shù)據(jù)庫SCIE收錄，得到了廣泛的認(rèn)可。

該期刊投稿重要關(guān)注點(diǎn)：

預(yù)計(jì)審稿時(shí)間：約2月
醫(yī)學(xué)
CARDIAC & CARDIOVASCULAR SYSTEMS
SCIE
中科院3區(qū)
非預(yù)警

Cite Score數(shù)據(jù)（2024年最新版）Catheterization And Cardiovascular Interventions Cite Score數(shù)據(jù)

CiteScore：5.4
SJR：0.948
SNIP：0.859

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Radiology, Nuclear Medicine and Imaging	Q1	83 / 333	75%
大類：Medicine 小類：Cardiology and Cardiovascular Medicine	Q2	105 / 387	72%

CiteScore 是由Elsevier(愛思唯爾)推出的另一種評價(jià)期刊影響力的文獻(xiàn)計(jì)量指標(biāo)。反映出一家期刊近期發(fā)表論文的年篇均引用次數(shù)。CiteScore以Scopus數(shù)據(jù)庫中收集的引文為基礎(chǔ)，針對的是前四年發(fā)表的論文的引文。CiteScore的意義在于，它可以為學(xué)術(shù)界提供一種新的、更全面、更客觀地評價(jià)期刊影響力的方法，而不僅僅是通過影響因子(IF)這一單一指標(biāo)來評價(jià)。

歷年Cite Score趨勢圖

中科院SCI分區(qū)Catheterization And Cardiovascular Interventions 中科院分區(qū)

中科院 2023年12月升級版 綜述期刊：否 Top期刊：否

大類學(xué)科	分區(qū)	小類學(xué)科	分區(qū)
醫(yī)學(xué)	3區(qū)	CARDIAC & CARDIOVASCULAR SYSTEMS 心臟和心血管系統(tǒng)	3區(qū)

中科院分區(qū)表 是以客觀數(shù)據(jù)為基礎(chǔ)，運(yùn)用科學(xué)計(jì)量學(xué)方法對國際、國內(nèi)學(xué)術(shù)期刊依據(jù)影響力進(jìn)行等級劃分的期刊評價(jià)標(biāo)準(zhǔn)。它為我國科研、教育機(jī)構(gòu)的管理人員、科研工作者提供了一份評價(jià)國際學(xué)術(shù)期刊影響力的參考數(shù)據(jù)，得到了全國各地高校、科研機(jī)構(gòu)的廣泛認(rèn)可。

中科院分區(qū)表 將所有期刊按照一定指標(biāo)劃分為1區(qū)、2區(qū)、3區(qū)、4區(qū)四個(gè)層次，類似于“優(yōu)、良、及格”等。最開始，這個(gè)分區(qū)只是為了方便圖書管理及圖書情報(bào)領(lǐng)域的研究和期刊評估。之后中科院分區(qū)逐步發(fā)展成為了一種評價(jià)學(xué)術(shù)期刊質(zhì)量的重要工具。

歷年中科院分區(qū)趨勢圖

JCR分區(qū)Catheterization And Cardiovascular Interventions JCR分區(qū)

2023-2024 年最新版

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q3	113 / 220	48.9%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q2	100 / 220	54.77%

JCR分區(qū)的優(yōu)勢在于它可以幫助讀者對學(xué)術(shù)文獻(xiàn)質(zhì)量進(jìn)行評估。不同學(xué)科的文章引用量可能存在較大的差異，此時(shí)單獨(dú)依靠影響因子(IF)評價(jià)期刊的質(zhì)量可能是存在一定問題的。因此，JCR將期刊按照學(xué)科門類和影響因子分為不同的分區(qū)，這樣讀者可以根據(jù)自己的研究領(lǐng)域和需求選擇合適的期刊。

歷年影響因子趨勢圖

發(fā)文數(shù)據(jù)

2023-2024 年國家/地區(qū)發(fā)文量統(tǒng)計(jì)

國家/地區(qū)數(shù)量
USA1168
Italy268
GERMANY (FED REP GER)172
England150
Japan150
Netherlands120
Canada117
CHINA MAINLAND111
France90
Spain77

本刊中國學(xué)者近年發(fā)表論文

1、Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study
Author: Qian, Juying; Wu, Yizhe; Li, Chenguang; Yin, Jiasheng; Fu, Guosheng; Wang, Jian'an; He, Yong; Ma, Genshan; Chen, Yundai; Xia, Yong; Li, Lang; Ji, Fusui; Zeng, Hesong; Wei, Meng; Nie, Shaoping; Jin, Huigen; He, Ben; Chen, Yuguo; Liu, Fan; Wang, Hui; Sun, Yingxian; Xu, Bo; Ge, Junbo

Journal: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2023; Vol. 101, Issue 1, pp. 33-43. DOI: 10.1002/ccd.30472
2、Plaque burden estimated from optical coherence tomography with deep learning: In vivo validation using co-registered intravascular ultrasound
Author: Huang, Jiayue; Tu, Shengxian; Masuda, Shinichiro; Ninomiya, Kai; Dijkstra, Jouke; Chu, Miao; Ding, Daixin; Hynes, Sean O. O.; O'Leary, Neil; Onuma, Yoshinobu; Serruys, Patrick W. W.; Wijns, William

Journal: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2023; Vol. 101, Issue 2, pp. 287-296. DOI: 10.1002/ccd.30525
3、Impact of implantation technique on conduction disturbances for TAVR with the self-expanding portico/navitor valve
Author: Wang, Xi; Wong, Ivan; Bajoras, Vilhelmas; Vanhaverbeke, Maarten; Nuyens, Philippe; Bieliauskas, Gintautas; Jorgensen, Troels Hojsgaard; Chen, Mao; De Backer, Ole; Sondergaard, Lars

Journal: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2023; Vol. 101, Issue 2, pp. 431-441. DOI: 10.1002/ccd.30517
4、Transcatheter tricuspid valve-in-valve implantation for degenerated surgical bioprosthesis
Author: Chen, Jinmiao; Yang, Ye; Song, Wenyu; Feng, Deguang; Yan, Yang; Wang, Chunsheng; Wei, Lai

Journal: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2023; Vol. 101, Issue 2, pp. 442-448. DOI: 10.1002/ccd.30554
5、Transcatheter aortic valve implantation in patients with anomalous coronary artery
Author: Bajoras, Vilhelmas; Dieckus, Laurynas; Wong, Ivan; Laurinaviciene, Anna; Davidavicius, Giedrius; Cesna, Sigitas

Journal: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2023; Vol. 101, Issue 2, pp. 485-493. DOI: 10.1002/ccd.30540
6、3D Printing-guided endovascular repair of enormous twisted thoracoabdominal aortic aneurysm with branch stenosis and occlusion
Author: Li, Wen-Dong; Keyoumu, Reyaguli; Wang, Chao; Liu, Zhao

Journal: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2023; Vol. , Issue , pp. -. DOI: 10.1002/ccd.30578
7、Early healing after treatment of coronary lesions by thin strut everolimus, or thicker strut biolimus eluting bioabsorbable polymer stents: The SORT-OUT VIII OCT study
Author: Andreasen, Lene N.; Balleby, Ida R.; Barkholt, Trine O.; Hebsgaard, Lasse; Terkelsen, Christian J.; Holck, Emil N.; Jensen, Lisette O.; Maeng, Michael; Dijkstra, Jouke; Antonsen, Lisbeth; Kristensen, Steen D.; Tu, Shengxian; Lassen, Jens F.; Christiansen, Evald H.; Holm, Niels R.

Journal: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2023; Vol. , Issue , pp. -. DOI: 10.1002/ccd.30579
8、Three-year clinical outcomes of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: A prospective patient-level pooled analysis of NeoVas trials
Author: Wang, Xiaozeng; Li, Yang; Fu, Guosheng; Xu, Bo; Zhou, Yujie; Su, Xi; Liu, Huiliang; Zhang, Zheng; Yu, Bo; Tao, Ling; Zheng, Qun; Li, Lang; Xu, Kai; Han, Yaling; NeoVas OPC Investigators

Journal: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS. 2023; Vol. , Issue , pp. -. DOI: 10.1002/ccd.30518